Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Levine

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
How long to treat acute venous thrombosis in cancer: can treatment be personalized?Punam Rana, Mark N Levine
The New England Journal of Medicine|November 3, 2006
Adjuvant chemotherapy for breast cancer--30 years laterMark N Levine, Timothy Whelan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Selective application of a test based on risk: using limited resources wiselyMark N Levine, Jim Julian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
Researching the cost of researchJames R Wright, Mark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Beyond the development of quality-of-life instruments: where do we go from here?Mark N Levine, Patricia A Ganz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Registries that show efficacy: good, but not good enoughMark N Levine, Jim A Julian
Circulation|June 20, 2003
Venous thromboembolism and cancer: risks and outcomesAgnes Y Y Lee, Mark N Levine
The Lancet. Haematology|April 1, 2016
Treating clots in cancer: moving closer to an answer?Mark N Levine, Sameer Parpia, Jim Julian
Pathophysiology of Haemostasis and Thrombosis|September 5, 2003
Risk assessment and primary VTE prevention in the cancer patientMark N Levine, Agnes Y Y Lee
JAMA|September 24, 2014
PET screening for metastatic colorectal adenocarcinoma--replyCarol-Anne Moulton, Karen Gulenchyn, Mark N Levine
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
How long to treat acute venous thrombosis in cancer: can treatment be personalized?Punam Rana, Mark N Levine
The New England Journal of Medicine|November 3, 2006
Adjuvant chemotherapy for breast cancer--30 years laterMark N Levine, Timothy Whelan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Selective application of a test based on risk: using limited resources wiselyMark N Levine, Jim Julian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
Researching the cost of researchJames R Wright, Mark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Beyond the development of quality-of-life instruments: where do we go from here?Mark N Levine, Patricia A Ganz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Registries that show efficacy: good, but not good enoughMark N Levine, Jim A Julian
Circulation|June 20, 2003
Venous thromboembolism and cancer: risks and outcomesAgnes Y Y Lee, Mark N Levine
The Lancet. Haematology|April 1, 2016
Treating clots in cancer: moving closer to an answer?Mark N Levine, Sameer Parpia, Jim Julian
Pathophysiology of Haemostasis and Thrombosis|September 5, 2003
Risk assessment and primary VTE prevention in the cancer patientMark N Levine, Agnes Y Y Lee
JAMA|September 24, 2014
PET screening for metastatic colorectal adenocarcinoma--replyCarol-Anne Moulton, Karen Gulenchyn, Mark N Levine
Pageof 12